Task force on clinical (drug) trials

a member


Task force on clinical (drug) trials

Vision and mission of the Task Force

Vision of the task force

Treatment aimed at improving the long-term outlook of children with heart disease requires the development of adequate drug treatment for common problems in these, including:

  • neurodevelopmental problems
  • impaired exercise tolerance
  • circulatory failure
  • cardiac arrhythmias

Mission of the task force

The task force on clinical drug trials within the AEPC is dedicated to:

  • Provide the paediatric cardiology platform for clinical drug research
  • Contribute to improve, generalize and harmonize existing good practice
  • Improve trial design
  • Consistent delivery of high quality data
  • Integrate perspectives / needs of children and their families’ into the process
  • For this purpose we join forces with patients, scientists from adjacent fields, public funders, pharma industry and regulators

Council of the task force

Damien Bonnet

Chairman (2024-2027)

Hospital Necker Enfants Malades, Service de Cardiologie Congeniale et Pediatrique
Rue de Sevres 149, F-75015 Paris, France

Michal Odermarsky

Michal Odermarsky

Secretary (2024-2027)

Children Heart Center, Skane University Hospital
Lasarettsgatan 48, 22185 Lund, Sweden
Telephone: +46 46 177481 - Cell: +46 763367368
Liaison to EMA


Estelle Naumburg

Treasurer (2024-2027)

Dept of Clinical Sciences, Umeå University, Pediatrics
Kyrkgatan 14, Östersunds sjukhus, Umeå University
Östersund, Sweden


back to homepage